You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Abbott Laboratories Return vs. S&P
|5 Year Annualized
Abbott Laboratories Company Info
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
News & Analysis
Dividend Kings of 2024
Get a list of current -- and potential future -- Dividend Kings and learn how to leverage these strong companies to build wealth.
Abbott Laboratories Is the Latest Company to Get Involved in the Weight Loss Market. Here's How.
Abbott Labs has an impressive portfolio of nutrition drinks, and its latest addition could help it profit from a new market: people taking prescribed weight loss drugs.
These 2 Stocks Are Trying to Ride the Ozempic Bandwagon: Are They Buys?
There's room for multiple winners in the fast-growing weight-loss market.
2 Stocks to Buy Near Their 52-Week Highs
It's not too late to invest in these stocks.
2 Healthcare Dividend Kings to Buy and Hold Forever
It's going to take a lot to interrupt these companies' streaks.
Is Abbott Laboratories Stock a Buy Now?
Can Abbott Laboratories be a reliable income stock to hang on to now?
Could Abbott Labs Be the Next Big Winner in the Billion-Dollar Weight Loss Market?
Abbott Labs is using its well-established strengths to make gains in the weight loss market.
20 High-Yield Dividend Stocks to Buy in 2024
A list of high-yielding dividend stocks to consider buying now.
Abbott Laboratories (ABT) Q4 2023 Earnings Call Transcript
ABT earnings call for the period ending December 31, 2023.
Abbott Laboratories (ABT) Q3 2023 Earnings Call Transcript
ABT earnings call for the period ending September 30, 2023.
Abbott Laboratories (ABT) Q2 2023 Earnings Call Transcript
ABT earnings call for the period ending June 30, 2023.
Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript
ABT earnings call for the period ending December 31, 2022.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.